glioblastoma — grants

Sort

11,323 grants matching “glioblastoma”

Integrated ligand and target discovery by chemical proteomics for glioblastoma treatment.

$696,619

Paul S Mischel · Stanford University · R01 · FY2021 · CA

Spatial and Temporal Tracking of Neural Stem Cells Migration to Brain Metastases of Breast Cancer using High Resolution Imaging

$696,133

Irina V Balyasnikova · Northwestern University At Chicago · R01 · FY2025 · CA

Organ-specific, Blood Protein Biomarkers for an Informative Diagnosis of Brain an

$695,840

Leroy E Hood · California Institute Of Technology · U54 · FY2011 · CA

A randomized controlled phase 2 study of the ketogenic diet for patients with newly diagnosed glioblastoma in combination with standard-of-care treatment

$695,258

Jethro Hu · Cedars-Sinai Medical Center · R01 · FY2024 · CA

Targeting T cell dysfunction in glioblastoma: A proof-of-concept Phase 0/I trial of anti-TIGIT antibody AB154 in combination with anti-PD1 antibody AB122

$695,125

Antonio M Omuro · Yale University · R01 · FY2022 · CA

Sonodynamic therapy using MRI-guided focused ultrasound in combination with 5-aminolevulinic acid to treat recurrent glioblastoma multiforme

$694,814

Stuart Marcus · Sonalasense Inc · R44 · FY2023 · CA

Quantitative Non-Contrast Perfusion using Arterial Spin Labeling for Assessment of Cancer Therapy Response

$694,766

Ananth J Madhuranthakam · Ut Southwestern Medical Center · U01 · FY2020 · CA

The impact of interstitial fluid flow on CAR T cell trafficking, distribution, and efficacy

$694,724

Jennifer M Munson · Virginia Polytechnic Inst And St Univ · R01 · FY2021 · NS

The Dana-Farber Cancer Institute Cancer Target Discovery and Development Center

$693,679

William C Hahn · Dana-Farber Cancer Inst · U01 · FY2014 · CA

Cytochrome C Oxidase: Biomarker In Newly Diagnosed Glioblastoma Multiforme

$693,029

Corinne E. Griguer · University Of Alabama At Birmingham · U01 · FY2016 · NS

Identifying and Targeting 3D Regulatory Nodes that Maintain Glioblastoma Programs.

$692,990

Effie Apostolou · Weill Medical Coll Of Cornell Univ · R01 · FY2024 · NS

Molecular Profiling of Patients Undergoing Radiotherapy

$691,574

Kevin Camphausen · Division Of Clinical Sciences - Nci · ZIA · FY2013 · CA

Project 1: Targeting cytomegalovirus antigens in glioblastoma with regulatory T cell depletion

$691,384

John H Sampson · Duke University · P01 · FY2020 · CA

Integrating circulating tumor DNA assay and protein-based MRI to accurately monitor glioma therapy

$691,360

Shanshan Jiang · Johns Hopkins University · R01 · FY2023 · CA

Adoptive Transfer of AlloCTL for Immunotherapy of Recurrent Gliomas

$690,480

Carol A Kruse · University Of California Los Angeles · R01 · FY2011 · CA

Brain Tumors - Immunological and Biological Studies

$690,468

Darell D Bigner · Duke University · R37 · FY2009 · CA

Genetic evolution of glioblastomas during radiation and temozolomide therapy

$689,449

Rameen Beroukhim · Dana-Farber Cancer Inst · R01 · FY2017 · CA

Understanding and manipulating programmed cell death (PCD) pathways to facilitate lymphoid tumor killing by CAR T cells

$689,091

Marcela Valderrama Maus · Massachusetts General Hospital · R01 · FY2023 · CA

The Dana-Farber Cancer Institute Cancer Target Discovery and Development Center

Identification of Modifier Gene of Tumors Associated with NF1 and Astrocytoma

Gutless Adenovirus Mediated Gene Therapy for Glioma

Microenvironmental regulation of glioblastoma radiosensitivity

Evolution of gliomas during treatment and resistance

Control of Protein Translation in Cancer Pathogenesis

Genetic evolution of glioblastomas during radiation and temozolomide therapy

Integrated ligand and target discovery by chemical proteomics for glioblastoma treatment.

Spatial and Temporal Tracking of Neural Stem Cells Migration to Brain Metastases of Breast Cancer using High Resolution Imaging

Organ-specific, Blood Protein Biomarkers for an Informative Diagnosis of Brain an

A randomized controlled phase 2 study of the ketogenic diet for patients with newly diagnosed glioblastoma in combination with standard-of-care treatment

Targeting T cell dysfunction in glioblastoma: A proof-of-concept Phase 0/I trial of anti-TIGIT antibody AB154 in combination with anti-PD1 antibody AB122

Sonodynamic therapy using MRI-guided focused ultrasound in combination with 5-aminolevulinic acid to treat recurrent glioblastoma multiforme

Quantitative Non-Contrast Perfusion using Arterial Spin Labeling for Assessment of Cancer Therapy Response

The impact of interstitial fluid flow on CAR T cell trafficking, distribution, and efficacy

The Dana-Farber Cancer Institute Cancer Target Discovery and Development Center

Cytochrome C Oxidase: Biomarker In Newly Diagnosed Glioblastoma Multiforme

Identifying and Targeting 3D Regulatory Nodes that Maintain Glioblastoma Programs.

Molecular Profiling of Patients Undergoing Radiotherapy

Project 1: Targeting cytomegalovirus antigens in glioblastoma with regulatory T cell depletion

Integrating circulating tumor DNA assay and protein-based MRI to accurately monitor glioma therapy

Adoptive Transfer of AlloCTL for Immunotherapy of Recurrent Gliomas

Brain Tumors - Immunological and Biological Studies

Genetic evolution of glioblastomas during radiation and temozolomide therapy

Understanding and manipulating programmed cell death (PCD) pathways to facilitate lymphoid tumor killing by CAR T cells